UPMC enrolling children in pediatric COVID-19 vaccine trial

The trial will evaluate the effectiveness of the vaccine in children aged 6 months to 12 years.

PITTSBURGH — Pittsburgh’s UMPC Children’s Hospital is enrolling children in a pediatric COVID-19 vaccine trial.

The site is one of 100 in the US and Canada participating in the Moderna “KidCOVE” vaccine trial, with an expected enrollment of 7,050 children.

The trial will evaluate the effectiveness of the vaccine in children aged 6 months to 12 years.

The Moderna vaccine is currently approved for those ages 18 and older, although the company filed on June 10 for an emergency FDA approval to give the vaccine to 12-to-17-year-olds.

“Now that they’ve seen how the vaccines have really changed what adults can do in this world, I think people are now interested in seeing if we can’t get doses in children now so we can ease some of their restrictions,” said Dr. Judy Martin, professor of pediatrics at the University of Pittsburgh School of Medicine and Children’s Hospital of Pittsburgh.

As part of the double-blind trial, 75 percent of trial participants will receive the vaccine, while 25 percent will receive a placebo.

The trial will take place in several phases, initially testing 6 to 12-year-olds. Full results are expected in early 2022.

You can register here for possible participation in the Pittsburgh site of the trial.

RELATED: Clinical trials are underway for children under 12 who receive the COVID-19 vaccine

RELATED: Can You Mix and Match COVID-19 Vaccines?

Comments are closed.